press_release_conclusion: Breast cancer survivors treated with chemotherapy could be lacking sufficient antibodies to protect against common illnesses, as chemotherapy reduces the body's immune response, according to research published in the open access journal Breast Cancer Research. This work raises the possibility that these survivors could benefit from additional post-treatment monitoring. Further work is required to assess if revaccination would be beneficial.
abstract_conclusion: Breast cancer chemotherapy is associated with long-term changes in immune parameters that should be considered during clinical management.